Eli Lilly and Company Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Eli Lilly and Company income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue65.1845.0434.1228.5428.3224.5422.3221.49
Cost of Revenue11.058.427.086.637.315.484.724.68
Gross Profit54.1336.6227.0421.9121.0119.0617.6016.81
Operating Expenses
Research & Development13.3410.9913.117.196.936.095.605.05
Selling, General & Administrative11.098.137.406.446.436.126.215.98
Operating Expenses24.4319.1220.5213.6313.3612.2111.8111.03
Operating Income29.7017.506.538.287.646.855.795.79
Other Income/Expense
Interest Income0.150.180.170.060.030.030.000.16
Interest Expense-0.640.780.490.330.34-0.360.000.24
Other Income/Expense0.04-4.82-0.10-1.21-1.17-1.17-0.29-2.02
Income
Income Before Tax25.7312.686.556.816.167.235.273.68
Income Tax Expense5.092.091.310.560.571.040.630.53
Net Income20.6410.595.246.245.586.198.323.23
Net Income - Continuous Operations20.6410.595.246.245.580.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA31.5815.236.558.668.048.916.595.53
EBIT29.7012.686.557.146.507.595.363.92
Depreciation & Amortization1.881.771.531.521.550.770.810.00
Earnings Per Share
Basic EPS23.0012.006.007.006.007.009.003.00
Diluted EPS23.0012.006.007.006.007.009.003.00
Basic Shares Outstanding0.900.900.900.950.950.910.931.03
Diluted Shares Outstanding0.900.900.900.950.950.910.941.03